Baptista T., Araujo de Baptista E., Ying Kin N., Beaulieu S., Walker C., Joober R., Lalonde J., Richard D. (2002). Comparative effects of the antipsychotics sulpiride or risperidone in rats. I: bodyweight, food intake, body composition, hormones and glucose tolerance, Brain Res, 957(1), 144-51.

Baptista T., Beaulieu S. (2002). The hypothesis of oestrogen withdrawal associated psychoses and the paradox of antipsychotic drug-induced hypoestrogenaemia, Acta Psychiatr Scand, 105(6), 473-4; author reply 474.

Baptista T., Beaulieu S. (2002). Are leptin and cytokines involved in body weight gain during treatment with antipsychotic drugs?, Can J Psychiatry, 47(8), 742-9.

Baptista T., Beaulieu S. (2002). Glucose metabolism, schizophrenia and antipsychotic drugs, Ann Clin Psychiat, 13, 241-242.

Baptista T., Kin N. M., Beaulieu S., de Baptista E. A. (2002). Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives, Pharmacopsychiatry, 35(6), 205-19.

Baptista T., Lacruz A., Paez X., Hernandez L., Beaulieu S. (2002). The antipsychotic drug sulpiride does not affect bodyweight in male rats. Is insulin resistance involved?, Eur J Pharmacol, 447(1), 91-8.

Baptista T., Ng Ying Kin N. M., Beaulieu S. (2002). Novel antipsychotics and severe hyperlipidemia: comments on the Meyer paper, J Clin Psychopharmacol, 22(5), 536-7; author reply 538.

Young L. T., Bakish D., Beaulieu S. (2002). The neurobiology of treatment response to antidepressants and mood stabilizing medications, J Psychiatry Neurosci, 27(4), 260-5.